concept

NEURONS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURONS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4971Connections

30Hypotheses

1Analyses

50Outgoing

50Incoming

1Experiments

1Debates

Summary

Neurons are the fundamental information-processing cells of the nervous system, transmitting electrical and chemical signals across synapses. The human brain contains approximately 86 billion neurons organized into circuits for perception, cognition, and motor control. Key subtypes include excitatory glutamatergic pyramidal neurons, inhibitory GABAergic interneurons (parvalbumin+, somatostatin+, VIP+), dopaminergic neurons (substantia nigra, VTA), and cholinergic neurons (basal forebrain). Selective neuronal vulnerability is a hallmark of neurodegeneration: entorhinal cortex layer II neurons in AD, dopaminergic neurons in PD, motor neurons in ALS, and medium spiny neurons in HD. Neuronal loss correlates more strongly with cognitive decline than amyloid plaques, driving interest in neuroprotective strategies.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	NEURONS
Key Genes/Proteins	3r-tau, 4r-tau, AB, ABCA1, ABCA7, ACHE
Related Diseases	acetylcholine, ACETYLCHOLINE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

cerebral-cortical-vasal-neurons

cell_type · 4639 words

→

Pathway Diagram

flowchart TD
    NEURONS["NEURONS"]
    PARKINSON["PARKINSON"]
    PARKINSON_S["PARKINSON'S"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    PARKIN(["PARKIN"])
    STING(["STING"])
    OPTN(["OPTN"])
    SPINAL_CORD["SPINAL CORD"]
    VCP(["VCP"])
    NEUROTRANSMISSION["NEUROTRANSMISSION"]
    PI3K(["PI3K"])
    REMYELINATION["REMYELINATION"]

    NEURONS -->|"activates"| PARKINSON
    NEURONS -->|"activates"| PARKINSON_S
    NEURONS -->|"activates"| PARKINSON_S_DISEASE
    NEURONS -->|"biomarker for"| PARKIN
    NEURONS -->|"biomarker for"| PARKINSON
    NEURONS -->|"biomarker for"| PARKINSON_S
    NEURONS -.->|"inhibits"| STING
    NEURONS -->|"causes"| OPTN
    NEURONS -->|"reduces"| SPINAL_CORD
    NEURONS -->|"expressed in"| SPINAL_CORD
    NEURONS -->|"activates"| VCP
    NEURONS -->|"contributes to"| VCP
    NEURONS -->|"stabilizes"| NEUROTRANSMISSION
    NEURONS -->|"activates"| PI3K
    NEURONS -.->|"inhibits"| REMYELINATION

    style NEURONS fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (1272)

Target	Relation	Type	Str
ds-f2c28aed24a7	data_in	dataset	1.00
Neurovascular Unit	component_of	process	0.95
Alzheimer's disease	associated_with	disease	0.90
Network Integration	involved_in	process	0.90
ALS	associated_with	disease	0.90
Signal Transmission	involved_in	process	0.90
Premature Senescence	associated_with	phenotype	0.90
neurodegeneration	expressed_in	disease	0.90
Neurodegenerative Diseases	associated_with	disease	0.90
neurodegeneration	activates	disease	0.90
Alzheimer's disease	activates	disease	0.90
neurodegeneration	associated_with	disease	0.90
neurodegeneration	regulates	disease	0.90
neurodegeneration	causes	disease	0.90
neuroinflammation	activates	disease	0.90
ALS	causes	disease	0.90
Neuroinflammation	involved_in	process	0.85
pyroptosis	active_in	pathway	0.85
autophagy pathway	active_in	pathway	0.85
Antimicrobial peptides	expressed_in	protein	0.85
mitochondrial function	active_in	pathway	0.85
Synaptic Properties	expressed_in	phenotype	0.85
epigenetic regulation	active_in	pathway	0.85
NAD+ metabolism	active_in	pathway	0.85
unfolded protein response	active_in	pathway	0.85
oxidative stress response	active_in	pathway	0.85
insulin signaling	active_in	pathway	0.85
Cancer Cells	interacts_with	cell_type	0.85
synaptic plasticity	active_in	pathway	0.85
neurotrophin signaling	active_in	pathway	0.85
glutamate signaling	active_in	pathway	0.85
cholesterol homeostasis	active_in	pathway	0.85
circadian regulation	active_in	pathway	0.85
brain-derived extracellular vesicles	mediates	compound	0.85
tau phosphorylation	activates	process	0.80
ALS	activates	disease	0.80
pyroptosis	activates	process	0.80
neuroinflammation	regulates	disease	0.80
Alzheimer's disease	interacts_with	disease	0.80
neurodegeneration	inhibits	disease	0.80
Parkinson's disease	associated_with	disease	0.80
Parkinson's Disease	associated_with	disease	0.80
ferroptosis	activates	process	0.80
neurodegeneration	interacts_with	disease	0.80
mitochondrial dysfunction	mediates	process	0.80
Proteasome Downregulation	expressed_in	process	0.80
NEURODEGENERATIVE DISEASES	targets	disease	0.80
PROTECTIVE EFFECTS	exerts	phenotype	0.80
neurodegeneration	implicated_in	process	0.80
MAPK signaling	active_in	pathway	0.75

Incoming (3699)

Source	Relation	Type	Str
ds-f2c28aed24a7	data_in	dataset	1.00
cell-types-dendritic-spine-degeneration-neurons	describes	wiki_page	1.00
Somatic Genomic Changes	associated_with	process	0.95
SLC45A1	expressed_in	protein	0.95
Mitochondrial Respiration	involved_in	process	0.95
Neuronal Surface Molecules	expressed_in	biomarker	0.95
Astrocytes	associated_with	cell_type	0.95
CX3CL1	interacts_with	protein	0.95
opsin	activates	protein	0.95
Epigenetic Modifications	involved_in	process	0.95
FTLD	expressed_in	gene	0.90
synaptic vesicle	found_in	organelle	0.90
BDNF-TrkB signaling	active_in	pathway	0.90
HDAC6	expressed_in	gene	0.90
endosome	found_in	organelle	0.90
TfR1	expressed_in	protein	0.90
adenosine	released_by	neurotransmitter	0.90
GDNF	expressed_in	gene	0.90
cGAS-STING	active_in	pathway	0.90
ALS	accumulates_in	gene	0.90
purinergic receptor	expressed_in	receptor	0.90
CYP46A1	expressed_in	gene	0.90
unfolded protein response	active_in	pathway	0.90
Alzheimer's Disease	targets	disease	0.90
Tat-NTS peptide	protects_against	compound	0.90
DNA	disrupts	gene	0.90
adeno-associated viruses	targets	drug	0.90
serotonin	released_by	neurotransmitter	0.90
adenosine receptor	expressed_in	receptor	0.90
AMPK	expressed_in	gene	0.90
NLRP3	expressed_in	gene	0.90
dopamine receptor	expressed_in	receptor	0.90
nicotinic receptor	expressed_in	receptor	0.90
MAPK	expressed_in	gene	0.90
ALS	disrupts	gene	0.90
ROS	expressed_in	gene	0.90
NMDA receptor	expressed_in	receptor	0.90
SYN1	expressed_in	gene	0.90
NGF	expressed_in	gene	0.90
STING	activates	gene	0.90
SST	expressed_in	gene	0.90
Optogenetics	activates	process	0.90
ALS	protects_against	gene	0.90
Parkinson's Disease	targets	disease	0.90
Amyotrophic Lateral Sclerosis	targets	disease	0.90
TOM40	expressed_in	protein	0.90
ALS	affects	disease	0.90
Parkinson's disease	affects	disease	0.90
aging	affects	disease	0.90
axon	found_in	organelle	0.90

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop transcranial focused ultrasound targeting EC-II	0.948	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop optogenetic targeting PV interneurons to restore	0.944	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting CA1 PV interneurons	0.927	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II	0.922	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur	0.900	Alzheimer's disease	Circuit-level neural dynamics in neurode

Closed-loop tACS targeting EC-II SST interneurons to block t	0.896	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to enhance	0.867	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II PV interneuro	0.863	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress	0.857	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II parvalbumin interneurons to	0.831	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting CA1 PV	0.797	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting entorhinal cortex layer II SST in	0.784	Alzheimer's disease	Circuit-level neural dynamics in neurode
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi	0.720	neurodegeneration	What are the mechanisms by which gut mic
Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Rep	0.680	neurodegeneration	epigenetic reprogramming aging neurons
Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neu	0.680	neurodegeneration	What are the mechanisms by which gut mic
Microglial NOX2 establishes an inflammatory ROS propagation	0.680	neurodegeneration	What mechanisms drive the self-amplifyin
TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Ca	0.678	neurodegeneration	What mechanisms underlie neuronal resist
OPTN/TBK1 mutations create selective vulnerability by blocki	0.670	neurodegeneration	What are the neuron-specific effects of
Layer V excitatory neurons show selectively enhanced vulnera	0.632	Alzheimer's disease	SEA-AD Single-Cell Analysis: Cell-Type V
Restoration of V-ATPase function reverses lysosomal acidific	0.630	neuroscience	Lysosomal dysfunction and cathepsin leak
Enhanced MCU Activity Primes mPTP Opening in Motor Neurons	0.620	neurodegeneration	What determines the specificity of TDP-4
SUV39H1 Restoration Represses Aberrant Transposon Expression	0.620	neurodegeneration	Investigate mechanisms of epigenetic rep
Basal forebrain NGF/TrkA trophic failure is an upstream trig	0.610	neurodegeneration	What determines the temporal sequence of
Aβ-induced downregulation of circPDS5B derepresses TDP-43 mR	0.595	neurodegeneration	What mechanisms drive TDP-43 pathology s
PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5	0.584	neurodegeneration	How does PIKFYVE inhibition activate unc
Impaired TFEB/TFE3 Nuclear Translocation Due to mTORC1 Hyper	0.578	neurodegeneration	What mechanisms underlie neuronal resist
Closed-loop tACS targeting EC-II somatostatin interneurons t	0.564	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting entorh	0.564	Alzheimer's disease	Circuit-level neural dynamics in neurode

Mentioning Analyses (1)

Scientific analyses that reference this entity

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

Experiments (1)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn	clinical	Alzheimer's disease and relate	0.950	0.00	human patients	proposed	N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

All participants identified brain delivery as a critical barrier, but no mechani

closed · Rounds: 4 · Score: 0.50 · 2026-04-16

Related Research

Hypotheses and analyses mentioning NEURONS in their description or question text

NEURONS

Understanding Entity Pages

Summary

Wiki Pages (1)

cerebral-cortical-vasal-neurons

Pathway Diagram

Outgoing (1272)

Incoming (3699)

Targeting Hypotheses (30)

Mentioning Analyses (1)

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

Experiments (1)

Related Papers (0)

Debates (1)

All participants identified brain delivery as a critical barrier, but no mechani

Related Research

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and r

Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibiti

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and bl

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhyth

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST inter

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with r

Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activa

Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfolding in Enteric Neuron

Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Repression of Synaptic

Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neurons

Microglial NOX2 establishes an inflammatory ROS propagation loop around vulnerab

TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neuro

OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-inde